Altria Group Inc. investors will want to note the latest setbacks for e-cigarette manufacturer Juul Labs, which include regulatory troubles, adverse publicity around the health effects of vaping, and numerous lawsuits.
247sarah With investments in booze, pot, tobacco and e-cigarettes, Altria has the sin category just about covered. However, the COVID-19 outbreak may indicate that the cost of sin has limits.
A combination of financial factors creates an interesting value proposition for investors as Altria reports later this week. Also, we will get a chance to see if anything happens with the dividend.
Chris Lange Since the beginning of the year, tobacco giant Altria saw its stock price dive. Investors may wonder if the dividend is safe.
It’s no secret that the cannabis industry has been smoked so far in 2020. Out of this group, Organigram seems to have fared the best. What comes next?
The U.S. Federal Trade Commission has filed a lawsuit alleging that Altria Group's $12.8 billion investment in e-cigarette maker Juul violated various U.S. antitrust laws.
Investors are scrambling to find yield. Could Altria have just the dividend yield they are looking for? Cigarettes have been considered recession-proof, but this time things may be somewhat different.
Chris Lange It's no secret that Altria enjoys its relative position in the hearts of Wall Street traders because of its dividend yield. Can the tobacco products giant maintain that high yield?
Monday's top analyst calls included AGNC Investment, Altria, BP, Broadcom, Caterpillar, Exxon Mobil, FedEx, Hess, Nvidia and Occidental Petroleum.
Wednesday's top analyst upgrades, downgrades and initiations included Altria, Beyond Meat, Chevron, Chipotle Mexican Grill, Epizyme, FedEx, Home Depot, Mattel, Morgan Stanley, Oracle, Qualcomm and Target.
These four top stocks have paid consistent and rising dividends for years, and they are good choices for investors with a higher risk tolerance who are seeking income, especially after their share…
Canadian cannabis stocks have performed poorly, in due to the sharp drop in share prices that marijuana stocks suffered last year. Yet, Organigram seemed to be positioned for a better year in…
Altria decided to hedge traditional tobacco industry bets with a huge investment in Juul, the electronic cigarette company. But that was before Juul was clobbered by federal regulators.
Douglas A. McIntyre The attorneys general of 39 states have launched an investigation into the sales and marketing practices of e-cigarette maker Juul. Altria, makers of Marlboro cigarettes, paid $12.8 billion in 2018 for a…
Paul Ausick These so-called sin stocks look like outstanding values and should hold up reasonably well even in a protracted bear market.
